These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 21384087

  • 1. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
    Delage M, Samimi M, Atlan M, Machet L, Lorette G, Maruani A.
    Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
    [Abstract] [Full Text] [Related]

  • 2. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, Bachelez H, Morel P, Lebbé C.
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM, Armario-Hita JC.
    Dermatology; 2007 Apr; 215(1):41-4. PubMed ID: 17587838
    [Abstract] [Full Text] [Related]

  • 7. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [Abstract] [Full Text] [Related]

  • 8. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M, Gkalpakiotis S, Arenberger P.
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.
    Lesage C, Adnot-Desanlis L, Perceau G, Bonnet M, Palot JP, Bernard P, Reguiaï Z.
    Eur J Dermatol; 2012 Dec; 22(5):640-4. PubMed ID: 22759562
    [Abstract] [Full Text] [Related]

  • 10. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E.
    J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
    [Abstract] [Full Text] [Related]

  • 11. [Hidradenitis suppurativa. Response to treatment with infliximab].
    Pedraz J, Daudén E, Pérez-Gala S, Goiriz-Valdés R, Fernández-Peñas P, García-Diez A.
    Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
    Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB.
    Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
    De Souza A, Solomon GE, Strober BE.
    Bull NYU Hosp Jt Dis; 2011 Aug; 69(2):185-7. PubMed ID: 22035400
    [Abstract] [Full Text] [Related]

  • 16. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A, Sinclair R, Foley P, Saunders H.
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [Abstract] [Full Text] [Related]

  • 17. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C, Buckley C.
    Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
    [Abstract] [Full Text] [Related]

  • 18. Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
    Van Rappard DC, Mekkes JR.
    Br J Dermatol; 2012 Jul; 167(1):206-8. PubMed ID: 22229974
    [No Abstract] [Full Text] [Related]

  • 19. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, Petropoulou H, Baziaka F, Karagianni V, Stavrianeas N, Giamarellou H.
    Br J Dermatol; 2008 Mar; 158(3):567-72. PubMed ID: 18076705
    [Abstract] [Full Text] [Related]

  • 20. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA, Callejas-Rubio JL, Sánchez-Cano D, González-Martínez FJ, Navas-Parejo A, Ortego-Centeno N.
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.